Glycolipids as the Major Autoantigens of Cytoplasmatic Islet Cell Antibodies

References

• Andreani D., Di Mario U., Pozzilli P. Prediction, Prevention, and Early Intervention in Insulin-Dependent Diabetes. Diabetes/Metabolism Reviews 1991; 7: 61–67
   Google Scholar
• Bottazzo G. F., Florin-Christensen A., Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; ii: 1279–1283
   Google Scholar
• McCuish A. C., Barnes E. W., Irvine W. J., Duncan J. P. Antibodies in Pancreatic islet cells in insulin-dependent diabetes with coexistent autoimmune disease. Lancet 1974; ii: 1529–1532
   Google Scholar
• Colman P. G., Nayak R. C., Campbell A. L., Eisenbarth G. S. Binding of cytoplasmic islet cell antibodies is blocked by human pancreatic glycolipid extracts. Diabetes 1985; 37: 645–652
   Google Scholar
• Nayak R. S., Omar M. A. K., Rabizadeh A., Srikanta S, Eisenbarth G. S. “Cytoplasmic” islet cell antibodies: evidence that the target antigen is a sialoglycoconjugate. Diabetes 1985; 34: 617–619
   PubMed Web of Science ®Google Scholar
• Portoukalian J., Rebbaa A., Thivolet C. Detection on thin layer plates of antibodies to human pancreatic gangliossides in the sera of type 1 diabetes patients. Diabetes, 39: 247A
   Google Scholar
• Previti M., Tiberti C., Dotta F., Lenti L., Pontieri G. M., Andreani D., Di Mario U. Ganglioside characterization of human and rat pancreas: their role in endocrine auto-4immunity. J. Endocrinol. Invest 1990; 13: 63
   Google Scholar
• Portoukalian J., Rebbaa A., Thivolet C. H. Detection on thin layer plates of autoantibodies to human pancreatic fucogangliosides in the sera of ICA positive type 1 diabetic patients. Diabetologia. 1990; 33: 155A
   Google Scholar
• Cabrera E., Fernandez L. E., Carr A., Marquina G., Valiente O., Uriarte A., Rynmark B. M., Fredman P., Svennerholm L. Which glycolipids are the autoantigens of cytoplasmatic islet cell antibodies?. Acta Diabetologica. 1992; 29: 70–74
   Google Scholar
• Harrison L. C. Multiple islet antigens in IDDM: order out of chaos?. International diabetes monitor 1992; 4: 1–6
   Google Scholar
• Feizi T. Demonstration by monoclonal antibodies that carbohidrate structures of glycoproteins and glycolipids are oncodevelopmental antigens. Nature 1985; 314: 53–56
   PubMed Web of Science ®Google Scholar
• Hakomori S. I. Glycolipids in cellular interaction, differentiation, and oncogenesis. Ann. Rev. Biochem. 1981; 50: 733–744
   PubMed Web of Science ®Google Scholar
• Marcus D. M. A review of the immunogenic and immunomodulatory of glycosphingolipids. Mol. Immunol. 1984; 21: 1083–1092
   PubMed Web of Science ®Google Scholar
• Ariga T., Yoshida T., Mimori T., Yu R. K. Autoantibodies against Forssman glycolipids in Graves' disease and Hashimoto's thyroiditis. Clin. exp. Immunol. 1991; 86: 483–488
   PubMedGoogle Scholar
• Buchard K., Josefsen K., Rygaard J., Spitalnik S. L. Pancreatic islet cell epitope recognized by an anti-sulphatide monoclonal antibody. APMIS 1991; 99: 1151–1156
   Google Scholar
• Gianani R., Pugliese A., Bonner-Weir S., Shiffrin Soeldner J. S., Erlich Awdeh Z., Alper C. A., Jackson R. A., Eisenbarth G. S. Prognostically Significant Heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type 1 diabetes. Diabetes 1992; 41: 347–353
   PubMed Web of Science ®Google Scholar
• Bottazzo G. F., Genovese S., Bosi E., Dean B. M., Christie M. R., Bonifacio E. Novel considreation on the anti-body/autoantigen system in type 1 (insulin-dependent) diabetes mellitus. Ann. Med. 1991; 23: 453–461
   PubMed Web of Science ®Google Scholar
• Rotella C. M., Dotta F., Mannucci E., Di Mario U. Autoantigens in thyroid and islet autoimmunity: similarities and differences. Autoimmunity 1992; 12: 223–237
   PubMed Web of Science ®Google Scholar
• Svennerholm L. Quantitative estimation of sialic acids. A colorimetric resorcinol-hydrochloric acid method. Biochem Biophys Act 1957; 24: 604–608
   PubMed Web of Science ®Google Scholar
• Svennerholm L., Fredman P. A procedure for the quantitative isolation of brain gangliosides. Biochem. Biophys. Act. 1980; 617: 97–109
   PubMed Web of Science ®Google Scholar
• Bottazzo G. F., Gorsuch A. N., Dean B. M., Cubworth A. G., Doniach D. Complement-fixing islet cell antibodies in type 1 diabetes: possible monitors of active B cell damage. Lancet 1980; I: 668–672
   Google Scholar
• Fulthrope A. J., Roitt I. M., Doniach D., Couchman K. A stable sheep cell preparation for detecting thyro-globulin autoantibodies and its clinical applications. J. Clin. Pathol. 1961; 14: 654–660
   Google Scholar
• Vardi P., Dib S. A., Tuttleman M., Connelly J. E., Grinbergs M., Rabizadeh A., Riley W. J., MacLaren N. K., Eisenbarth G. S., Soeldner J. S. Competitive insulin autoantibody assay: prospective evaluation of subjects at high risk for development of type i diabetes mellitus. Diabetes 1987; 36: 1286–1291
   PubMed Web of Science ®Google Scholar
• Scott-Morgan L., Keller U., Heitz P., Mirza I., Diaz J. L., Casey C., Wilkin T. Insulin autoantibodies (IAA) may cause false positive islet cell antibody (ICA) results in the indirect immunofluorescence test. Diabetes Research 1988; 8: 45–8
   Google Scholar
• Riley W. J., Maclaren N. K. Islet cell autoantibodies. The endocrine pancreas, E. Samols. Raven Press, New York, 409–422
   Google Scholar
• MacLaren N. K., Kaufman D. L., Atkinson M. A., Muir A., Holmes L., Newman D., Tobin A. J. A subset of islet cell cytoplasmic autoantibodies (ICA) in insulin dependent diabetes (IDD) are reactive to glutamate decarboxylase (GAD). Diabetes 1992; 41: 3–8A
   Google Scholar
• Atkinson M. A., Kaufman D. L., Newman D., Tobin A. J., MacLaren N. K. Islet cell cytoplasmatic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J. Clin. Invest. 1993; 91: 350–356
   PubMedGoogle Scholar
• Scherbaum W. A. Cytoplasmic islet cell antibodies (ICA): towards a molecular understanding of the autoantigens. Clinical Endocrinology 1994; 40: 15–18
   Google Scholar
• Genovese S., Bonifacio E., McNally J. M., Dean B. M., Wagner R., Bosi E., Gale E. A. M., Bottazzo G. F. Distinct cytoplasmatic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1992; 35: 385–388
   PubMed Web of Science ®Google Scholar